The powerhouse drug Avastin may be linked to severe kidney problems. June 11, 2010 -- Patients taking the anti-cancer drug Avastin may increase their risk of kidney damage, a new study says -- but ...

(Reuters) - Counterfeit versions of Roche's multi-billion cancer drug Avastin have been distributed in the United States, the Swiss drugmaker and its U.S. biotech unit Genentech said on Tuesday. Roche ...

ORLANDO, Florida (Reuters) - A study of blockbuster drug Avastin in colon cancer patients who have undergone surgery showed that the drug's effectiveness wore off after patients stopped taking it, ...

This is troubling on so many levels. The maker of the Avastin cancer drug is currently warning doctors and hospitals that a fake version of the drug has been found, and it's really hard to tell if you ...

The U.S. Food and Drug Administration has revoked its approval of the drug Avastin for breast cancer on the grounds that it has not been shown to be safe and effective for that use, according to an ...

One option for macular degeneration cuts treatment costs from $2,000 to $50. April 4, 2011— -- One drug costs $50 per dose. The other costs $2,000 per dose. Now, new research shows that the drug ...

September 26, 2006 — The US Food and Drug Administration (FDA) and Genentech, Inc, have notified healthcare professionals regarding safety labeling revisions for bevacizumab injection (Avastin) that ...

Aug. 13, 2004 — The U.S. Food and Drug Administration (FDA) and Genentech, Inc., sent a letter yesterday to healthcare professionals that warns of the risk for serious and fatal arterial ...

The Centers for Medicare and Medicaid Services (CMS) said Medicare will continue paying for Avastin for the treatment of metastatic breast cancer, despite a Food and Drug Administration (FDA) panel’s ...

Here we go again. The U.S. Food and Drug Administration’s decision earlier this month to withdraw approval for the cancer drug Avastin for treating women with advanced breast cancer was met with ...

WASHINGTON - The government delivered a blow to some desperate patients Friday as it ruled the blockbuster drug Avastin should no longer be used to treat advanced breast cancer. Avastin is hailed for ...